Motilent is transforming how IBD is measured, monitored, and understood - across clinical care, research, and patient engagement.
Fibrostenotic Crohn’s disease is complex, with strictures that are difficult to assess and treat. Motilent is creating imaging tools that capture treatment response and support better trials and patient outcomes.
MRI provides a non-invasive way to assess gastric emptying, accommodation, and motility. Validated against scintigraphy, barostat, and manometry, it offers unique insights into gastric function and supports both clinical care and research.
Exploring the challenges of perianal fistulas in Crohn’s disease and how new imaging and trial endpoints are advancing patient care.